KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Xylem (XYL) Shares Outstanding (2016 - 2026)

Xylem has reported Shares Outstanding over the past 16 years, most recently at $260.3 million for Q1 2026.

  • For Q1 2026, Shares Outstanding changed 0.23% year-over-year to $260.3 million; the TTM value through Mar 2026 reached $260.3 million, changed 0.23%, while the annual FY2025 figure was $259.9 million, 6.96% up from the prior year.
  • Shares Outstanding for Q1 2026 was $260.3 million at Xylem, roughly flat from $259.9 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $260.3 million in Q1 2026 and troughed at $180.3 million in Q4 2022.
  • A 5-year average of $238.5 million and a median of $258.6 million in 2024 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: dropped 0.08% in 2022 and later surged 33.98% in 2023.
  • Year by year, Shares Outstanding stood at $180.3 million in 2022, then surged by 33.98% to $241.5 million in 2023, then grew by 0.61% to $243.0 million in 2024, then grew by 6.96% to $259.9 million in 2025, then rose by 0.15% to $260.3 million in 2026.
  • Business Quant data shows Shares Outstanding for XYL at $260.3 million in Q1 2026, $259.9 million in Q4 2025, and $259.8 million in Q3 2025.